This increase in IL-27 was associated with improvements in blood lipid profiles and a reduction in insulin resistance, suggesting a possible role of IL-27 in mediating the anti-obesity effects of gut microbiota-modulating interventions, but further mechanistic investigations are needed to clarify the interactions between IL-27 and microbiota. This evidence concerns the gene IL27 and obesity due to melanocortin 4 receptor deficiency.